[HTML] frontiersin.org

[HTML][HTML] Circulating ceramide: a new cardiometabolic biomarker in patients with comorbid acute coronary syndrome and type 2 diabetes mellitus

R Cao, Z Fang, S Li, M Xu, J Zhang, D Han… - Frontiers in …, 2020 - frontiersin.org
Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …
被引用次数：16 相关文章

Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus

R Cao, Z Fang, S Li, M Xu, J Zhang… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …
[HTML] nih.gov

[HTML][HTML] Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus

R Cao, Z Fang, S Li, M Xu, J Zhang, D Han… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …

Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus

R Cao, Z Fang, S Li, M Xu, J Zhang… - New Drug Targets …, 2021 - books.google.com
Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute
Coronary Syndrome and Type 2 Diabetes Mellitus Page 191 ORIGINAL RESEARCH …

Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus.

R Cao, Z Fang, S Li, M Xu, J Zhang, D Han… - Frontiers in …, 2020 - europepmc.org
Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …